BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou Y, Petrovic J, Zhao J, Zhang W, Bigdeli A, Zhang Z, Berger SL, Pear WS, Faryabi RB. EBF1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells. Mol Cell 2022:S1097-2765(22)00058-2. [PMID: 35182476 DOI: 10.1016/j.molcel.2022.01.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cuartero S, Stik G, Stadhouders R. Three-dimensional genome organization in immune cell fate and function. Nat Rev Immunol 2022. [PMID: 36127477 DOI: 10.1038/s41577-022-00774-5] [Reference Citation Analysis]
2 Wang W, Chandra A, Goldman N, Yoon S, Ferrari EK, Nguyen SC, Joyce EF, Vahedi G. TCF-1 promotes chromatin interactions across topologically associating domains in T cell progenitors. Nat Immunol 2022. [PMID: 35726060 DOI: 10.1038/s41590-022-01232-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bayer M, Grosschedl R. How to resist Notch-targeted T-leukemia therapy: Lineage- and MYC enhancer switch. Mol Cell 2022;82:884-6. [PMID: 35245453 DOI: 10.1016/j.molcel.2022.02.015] [Reference Citation Analysis]